HCA Healthcare, Inc. $HCA Stock Sold by Oregon Public Employees Retirement Fund

Oregon Public Employees Retirement Fund reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.5% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 18,112 shares of the company’s stock after selling 1,053 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in HCA Healthcare were worth $7,729,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also made changes to their positions in the company. Sunbelt Securities Inc. increased its stake in shares of HCA Healthcare by 171.7% during the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after buying an additional 3,945 shares during the period. Sei Investments Co. lifted its stake in HCA Healthcare by 27.5% in the first quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after acquiring an additional 100,764 shares during the period. SEB Asset Management AB bought a new position in HCA Healthcare during the 1st quarter worth about $75,534,000. Darsana Capital Partners LP increased its position in HCA Healthcare by 46.7% during the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares during the period. Finally, Fund 1 Investments LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $975,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $510.31 on Thursday. The company has a market capitalization of $106.60 billion, a PE ratio of 16.91, a P/E/G ratio of 1.55 and a beta of 1.11. The company has a 50-day simple moving average of $440.51 and a two-hundred day simple moving average of $444.90. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. The firm had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.96 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 30.15 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 10.34%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research reports. Robert W. Baird upped their price target on shares of HCA Healthcare from $393.00 to $409.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 28th. TD Cowen lifted their price objective on shares of HCA Healthcare from $460.00 to $486.00 and gave the company a “buy” rating in a report on Wednesday, October 28th. UBS Group reduced their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research note on Monday, July 27th. JPMorgan Chase & Co. lowered their target price on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a report on Thursday, August 20th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $480.13.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Hospitals and health insurers rallied after Democrats’ midterm gains, a sector-wide move that likely helped lift HCA. The coverage does not specify which policy changes investors expect. Article: Health insurers, hospitals rally after sweeping midterm win for Democrats
• Positive Sentiment: HCA’s quarterly results beat expectations: adjusted earnings were $7.22 per share versus a $6.65 consensus estimate, and revenue was $19.85 billion versus $19.33 billion. Revenue grew 3.6% year over year. Article: Why HCA Healthcare is a top growth stock for the long term
• Positive Sentiment: Wells Fargo raised its price target on HCA, while Truist reaffirmed its Buy rating and lifted its target to $510 from $495. These moves signal continued analyst support. Article: HCA Healthcare stock gets price target boost from Wells Fargo Article: Truist reaffirms Buy rating
• Positive Sentiment: HCA Houston Healthcare Northwest introduced next-generation robotic-assisted surgical technology, which may strengthen its service offering and competitive position. Article: HCA Houston Healthcare Northwest introduces robotic-assisted surgical technology
• Neutral Sentiment: HCA is planning a $300 million hospital in Cape Coral, with $31 million in city incentives. The project supports expansion, though its investment and execution costs may take time to translate into returns. Article: Cape Coral lands $300 million HCA hospital
• Neutral Sentiment: HCA launched a senior-notes offering; the article listing does not provide details on terms or intended use of proceeds, so the effect on leverage is unclear. Article: HCA Healthcare launches senior notes offering
• Negative Sentiment: Uninsured-patient costs reportedly shifted by $400 million in HCA’s third-quarter payer mix, a potential headwind to profitability. Article: HCA Q3 revenue by payer as uninsured shift costs $400M
• Negative Sentiment: Reports of data breaches involving HCA raise potential privacy, regulatory, and reputational concerns; the article listing does not specify the impact. Article: Data breaches announced by HCA Healthcare
• Negative Sentiment: A law firm announced an investigation into claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but it can create legal and reputational uncertainty. Article: Pomerantz investigates claims on behalf of HCA investors

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.